"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network"
NCT ID: NCT05251298
Last Updated: 2023-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
370 participants
INTERVENTIONAL
2021-11-28
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interdisciplinary + Intersectoral Telemedicine Evaluation, Coordination + Treatment in RhineMain+ Parkinson's Network
NCT06479083
Advance Care Planning and Care Coordination for People With Parkinson's Disease
NCT05954013
Study of Motor Inhibition in Parkinson's Disease and Focal Hand Dystonia
NCT05209516
Study of Motor Control Mechanisms in DBS-implanted Parkinson's Disease Patients
NCT03714854
Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial
NCT00518791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Patients in the intervention group come from the same region (Münsterland) and will undergo therapies coordinated through the online platform.
Coordination through the online platform "JamesAKTIV"
Coordination of the treatment through the online platform "JamesAKTIV" that allows neurologists and therapists to select specialised therapies for the predominant symptoms of the patients and communicate easily about problems during the treatment
Control group
Patients in the control group will undergo their usual therapies as prescribed by their neurologists.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coordination through the online platform "JamesAKTIV"
Coordination of the treatment through the online platform "JamesAKTIV" that allows neurologists and therapists to select specialised therapies for the predominant symptoms of the patients and communicate easily about problems during the treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 30 years old or older
* place of residence: Münsterland, Tecklenburger Land, Kreis and Stadt Osnabrück
* sufficient knowledge of the German language, should be able to understand the consent form
Exclusion Criteria
* Atypical Parkinsonian Disorders
* participation in other studies
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
privates Institut für angewandte Versorgungsforschung GmbH
UNKNOWN
AOK PLUS
INDUSTRY
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Tobias Warnecke
Professor Dr. Tobias Warnecke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Münster, Klinik für Neurologie
Münster, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Achtert K, Huchtemann T, Altendorf M, Kerkemeyer L, Haring M, Lummer C, Frenz L, Becking T, Friedmann J, Mildner P, Schwarze K, Steinhaus L, Amelung V, Warnecke T. Design and implementation of ParkinsonAKTIV: an interventional study to evaluate the effectiveness of a novel online platform to guide quickcard-based treatment decisions. Neurol Res Pract. 2023 Jun 1;5(1):23. doi: 10.1186/s42466-023-00249-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01NVF19002
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2021-356-f-S
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.